Effect of sildenafil in patients with erectile dysfunction taking antihypertensive therapy

被引:151
作者
Kloner, RA
Brown, M
Prisant, LM
Collins, M
机构
[1] Hosp Good Samaritan, Inst Heart, Los Angeles, CA 90017 USA
[2] Univ So Calif, Dept Med, Los Angeles, CA USA
[3] Univ So Calif, Div Cardiol, Los Angeles, CA USA
关键词
erectile dysfunction; impotence; antihypertensive agents; sildenafil; drug safety;
D O I
10.1016/S0895-7061(00)01177-8
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Oral sildenafil is an effective treatment for erectile dysfunction (ED), which is a common complaint for patients with hypertension and those taking antihypertensive agents. This post hoc subanalysis assessed the efficacy and safety of sildenafil in men with ED who were receiving concomitant antihypertensive medication. Efficacy was assessed in 3414 men (1218 of whom were taking antihypertensive medication) who received sildenafil (5 to 200 mg) or placebo for 6 weeks to 6 months in 10 double-blind, placebo-controlled studies. The significant improvements in erectile function demonstrated by sildenafiltreated patients were comparable in patients taking and those not taking antihypertensive medication. Safety was assessed in 3975 men (1094 of whom were taking one or more antihypertensive agent, classified as a diuretic, beta -blocker, alpha (1)-blocker, angiotensin converting enzyme inhibitor, or calcium channel blocker), who received sildenafil or placebo in 18 double-blind, placebo-controlled studies. For patients taking sildenafil and antihypertensive medication, the incidence of treatment-related adverse events (34%) was similar to that for sildenafil-treated patients not taking any antihypertensive agent (38%). The incidences of the most common adverse events and of adverse events potentially related to blood pressure decreases leg, hypotension, dizziness, and syncope) were similar in both sildenatil groups. The number of antihypertensive medications taken from among the five classes had no effect on the adverse event profile of sildenafil. Sildenafil is an effective and well-tolerated treatment for ED in patients taking concomitant antihypertensive medication, including those on multidrug regimens. (C) 2001 American Journal of Hypertension, Ltd.
引用
收藏
页码:70 / 73
页数:4
相关论文
共 9 条
  • [1] DROLLER MJ, 1993, JAMA-J AM MED ASSOC, V270, P83
  • [2] IMPOTENCE AND ITS MEDICAL AND PSYCHOSOCIAL CORRELATES - RESULTS OF THE MASSACHUSETTS MALE AGING STUDY
    FELDMAN, HA
    GOLDSTEIN, I
    HATZICHRISTOU, DG
    KRANE, RJ
    MCKINLAY, JB
    [J]. JOURNAL OF UROLOGY, 1994, 151 (01) : 54 - 61
  • [3] Oral sildenafil in the treatment of erectile dysfunction
    Goldstein, I
    Lue, TF
    Padma-Nathan, H
    Rosen, RC
    Steers, WD
    Wicker, PA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (20) : 1397 - 1404
  • [4] Jackson G, 1999, AM J CARDIOL, V83, p13C
  • [5] Kloner RA, 1999, AM J CARDIOL, V83, P576
  • [6] Clinical safety of oral sildenafil citrate (VIAGRA™) in the treatment of erectile dysfunction
    Morales, A
    Gingell, C
    Collins, M
    Wicker, PA
    Osterloh, IH
    [J]. INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 1998, 10 (02) : 69 - 73
  • [7] SEXUAL DYSFUNCTION WITH ANTIHYPERTENSIVE DRUGS
    PRISANT, LM
    CARR, AA
    BOTTINI, PB
    SOLURSH, DS
    SOLURSH, LP
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (07) : 730 - 736
  • [8] The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction
    Rosen, RC
    Riley, A
    Wagner, G
    Osterloh, IH
    Kirkpatrick, J
    Mishra, A
    [J]. UROLOGY, 1997, 49 (06) : 822 - 830
  • [9] Webb DJ, 1999, AM J CARDIOL, V83, p21C